Evidence map›Paper›PMID 40385002›Full record

ArticleAmerican journal of translational research2025

Yaocheng Sun, Ying Shen, Yongmin Yan, Wei Luo, Chuanlei Liu, Jianjun Tang

Abstract read
In one paragraph

Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yaocheng SunDepartment of General Surgery, The Wujin Clinical College of Xuzhou Medical University Changzhou 213017, Jiangsu, China.
Ying ShenDepartment of Oncology, Wujin Hospital Affiliated with Jiangsu University Changzhou 213017, Jiangsu, China.
Yongmin YanWujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University Changzhou 213017, Jiangsu, China.
Wei LuoWujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University Changzhou 213017, Jiangsu, China.
Chuanlei LiuDepartment of General Surgery, The Wujin Clinical College of Xuzhou Medical University Changzhou 213017, Jiangsu, China.
Jianjun TangDepartment of General Surgery, The Wujin Clinical College of Xuzhou Medical University Changzhou 213017, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCancer cells exhibit altered metabolic profiles. Glutaminase 1 (

methods

results

conclusionsOur study suggests that

Indexed as

GLS1Hepatocellular carcinomalipid metabolismPI3K/AKT/mTORC1 signaling pathwaySREBP-1

Identifiers

PMID40385002
PMCPMC12082496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.